Nath Bio-Genes (India) Ltd.

₹137.74

-5.1 (-3.6%)

NATHBIOGEN Share Price

Agricultural Food & other Products

As on October 1, 2026

SectorFMCG

IndustryAgricultural Food & other Products

Basic IndustryOther Agricultural Products

Market Cap₹ 265.58 Cr

P/E Ratio6.29

Dividend Yield0.15 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	143.25	Bearish
10-DMA	146.2	Bearish
20-DMA	148.29	Bearish
50-DMA	153.62	Bearish
100-DMA	160.2	Bearish
200-DMA	156.4	Bearish

Historical Performance

1 Year

-16.4%

3 Years

-34%

5 Years

-57.6%

10 Years

17.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	4,451	3,649	3,326	3,014	2,784
Total Expenditure	3,925	3,149	2,827	2,524	2,411
Other Income	78	45	6	6	19
Operating Profit	604	546	506	495	391
Interest	162	107	92	104	106
Depreciation	40	38	33	30	31
Profit Before Tax	463	406	416	362	-634
Consolidated Net Profit	416	386	396	350	-674
Adjusted EPS	22	20	21	18	-35

Compounded Sales Growth

10 Years:9.8

5 Years:9.8

3 Years:8.1

TTM:4.1

Compounded Profit Growth

10 Years:-26.5

5 Years:-26.5

3 Years:3.5

TTM:1.5

Stock Price CAGR

10 Years:1.7

5 Years:-15.8

3 Years:-12.9

TTM:-17.5

Return on Equity

10 Years:N/A

5 Years:-35.5

3 Years:20.8

last year:21.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	190	190	190	190	190
Total Reserves	6,615	6,254	5,909	5,542	5,229
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	223	165	79	32	33
Other Current Liabilities	1,418	1,764	1,132	837	580
Short Term Borrowings	1,194	1,081	1,041	1,041	916
Total Liabilities	10,974	10,262	8,802	7,928	7,395
Capital Work in Progress	---	---	---	---	---
Long Term Loans & Advances	632	800	531	235	218
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	1,658	1,722	1,692	1,763	1,573
Total Current Assets	7,789	6,900	5,717	5,198	4,678
Total Assets	10,974	10,262	8,802	7,928	7,395
Adjusted Book Value	358	339	321	302	285

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of 6.29, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -12.9%, indicating poor shareholder returns.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹604 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹4451 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 825086.9

No. of Shares: 5990 (Approx)

Performance:-17.5%

-174913.1

NIFTY Performance: -9.9%

1 day Top Gainers